Literature DB >> 7571402

Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization.

S Mahalingam1, R G Collman, M Patel, C E Monken, A Srinivasan.   

Abstract

Vpr is a conserved HIV-1 auxiliary protein that localizes to the nuclear region of cells. Vpr is also present in virions, and it is directed into the assembling virus when coexpressed with Gag. Each of these two localization activities may be important for Vpr function, and we recently identified regions of Vpr that are critical for virion incorporation. In this study we analyzed the Vpr domains involved in subcellular localization. Immunofluorescence staining of transfected cells showed that wild-type Vpr localized exclusively to the nuclear region. Mutations in the N-terminal domain that were designed to disrupt a predicted alpha-helical structure resulted in aberrant localization, while conservative substitutions showed a wild-type pattern. A region in the central portion of the protein also has the potential for helical structure, and mutagenesis of two conserved amino acids in this domain (A59, H71) impaired localization, while substitution of a third (Q65) did not. In contrast, neither the conserved Gly and Cys at positions 75-76 nor the C-terminal basic residues (R87, K95) were necessary for nuclear localization. In addition, two-residue insertions within and between the two putative helices disrupted localization but insertion in the C-terminal region did not. Thus, Vpr's subcellular localization function depends on the two putative helical domains but is independent of the conserved Gly-Cys motif and of specific C-terminal basic residues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7571402     DOI: 10.1006/viro.1995.1490

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons.

Authors:  S C Piller; G D Ewart; D A Jans; P W Gage; G B Cox
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.

Authors:  S P Singh; B Tomkowicz; D Lai; M Cartas; S Mahalingam; V S Kalyanaraman; R Murali; A Srinivasan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr.

Authors:  Masakazu Kamata; Yuko Nitahara-Kasahara; Yoichi Miyamoto; Yoshihiro Yoneda; Yoko Aida
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.

Authors:  D Serio; T A Rizvi; M Cartas; V S Kalyanaraman; I T Weber; H Koprowski; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.

Authors:  R A Fouchier; B E Meyer; J H Simon; U Fischer; A V Albright; F González-Scarano; M H Malim
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.

Authors:  M A Vodicka; D M Koepp; P A Silver; M Emerman
Journal:  Genes Dev       Date:  1998-01-15       Impact factor: 11.361

7.  Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.

Authors:  M P Sherman; C M de Noronha; M I Heusch; S Greene; W C Greene
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 8.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

9.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.